The Best Survival Gear of 2025, According to an Expert
Whether it's a natural disaster, getting lost on a deer hunt, or unexpected breakdowns in everyday systems, having the right ...
BCLI: Plans Coming Together for Phase 3b Trial of NurOwn® in ALS…
BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Update on Planned Phase 3b Trial of NurOwn® in ALS On December 30, 2024, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) conducted an investor ...
ots3d
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in
Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the ...
Islands.com on MSN4d
The Ultimate 'Survival Guide' For A European Vacation
Surviving a European vacation can be more difficult than it may at first appear. These tips and tricks are essential for ...
The Times of Israel8h
With a possible end to the war in sight, will 2025 bring a startup ‘baby boom’?
Fund managers and tech executives worry about a shortage of local talent and new startups, but expect a revival of Israeli ...
Inside Climate News1d
A Nickel Rush Threatens Indonesia’s Last Nomadic Tribes and Its Forests, Fishermen and Farmers
The country holds nearly half of the world’s known deposits of a metal critical to the energy transition, but digging and ...
Stockhead on MSN3d
Dr Boreham’s Crucible: This cancer-tackling biotech might just have a fighting chance
Cell therapies have suffered from hyped-up expectations, clinical setbacks and high costs. But maybe, just maybe, Arovella is ...
Reality Sets In During First Monday of Congestion Pricing
Drivers, business owners and residents expressed mixed feelings after the first morning rush hour under New York City’s ...
The Citizen6d
The deindustrialisation of SA
The story of SA’s deindustrialisation over the last 50 years is alarming, and reversing it should be a priority for our ...
Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
Dyadic management will attend the J.P. Morgan Healthcare Conference in San Francisco, January 13–16, 2025. If you would like to schedule a meeting, please contact Dyadic at [email protected]. About ...
News Medical on MSN3d
New AI Tool Uses Routine Blood Tests to Predict Immunotherapy Response for Many Cancers
Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who ...